Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CHEMOURS CO : Change in Directors or Principal Officers (form 8-K)

09/01/2021 | 07:41am EDT

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 31, 2021, The Chemours Company ("Chemours") board of directors voted to appoint Sandra Phillips Rogers to the Chemours board of directors, which was announced on September 1, 2021. The appointment, which is effective October 1, 2021, increases the size of the board of directors to ten members, eight of which have been determined by the board of directors to be independent under the listing standards of the New York Stock Exchange and Chemours' Corporate Governance Guidelines.

Sandra Phillips Rogers, 55, currently serves as group vice president, chief legal officer, general counsel and corporate secretary of Toyota Motor North America (TMNA). In January of 2019, Ms. Rogers also took on the role of chief diversity officer (CDO) and oversight responsibility for Social Innovation, Sustainability and Regulatory Affairs and Compliance and Audit Office. Previously, Ms. Rogers was vice president and deputy general counsel, Toyota Motor Sales (TMS), U.S.A., Inc. and prior to joining Toyota in June 2012, Ms. Rogers was a partner at Morgan, Lewis & Bockius. She also previously served as senior vice president, associate general counsel and chief litigation counsel at Pfizer Inc., and was managing partner of the Houston office of Shook, Hardy & Bacon.

There are no arrangements or understandings between Ms. Rogers and any other persons in connection with her appointment. Ms. Rogers does not have any family relationships with any executive officer or director of Chemours and she is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Ms. Rogers has not yet been appointed to any committees of the board of directors.

Ms. Rogers will receive compensation as a non-employee director in accordance with the non-employee director compensation practices described in Chemours' Annual Proxy Statement filed with the Securities and Exchange Commission on March 12, 2021. Chemours and Ms. Rogers will also enter into Chemours' standard form of indemnification agreement filed as Exhibit 10.28 to Chemours' Annual Report on Form 10-K for the year ended December 31, 2015, filed with the Securities and Exchange Commission on February 25, 2016.


© Edgar Online, source Glimpses

10/17CHEMOURS : Traversing Obviousness Rejections
10/14CHEMOURS : Announces Dates for Third Quarter 2021 Earnings Release and Webcast Conference ..
10/08CHEMOURS CO : Entry into a Material Definitive Agreement, Creation of a Direct Financial O..
10/06CHEMOURS : Renews NHL Partnership to Provide Environmentally Sustainable Refrigerant Servi..
10/06CHEMOURS : NHL and Chemours Announce Multiyear Partnership Renewal, Expanding Successful C..
10/06The National Hockey League and The Chemours Company Announces Multiyear Renewal of Part..
10/04CHEMPOINT : Ti-Pure
09/29CHEMOURS CO : Change in Directors or Principal Officers (form 8-K)
09/29The Chemours Company Appoints Camela T. Wisel as Vice President, Chief Accounting Offic..
09/27CHEMOURS : Stock Up 10% Monday, Trading Volume Over Twice the Daily Average
More news
Analyst Recommendations on THE CHEMOURS COMPANY
More recommendations
Financials (USD)
Sales 2021 6 127 M - -
Net income 2021 482 M - -
Net Debt 2021 2 670 M - -
P/E ratio 2021 10,8x
Yield 2021 3,25%
Capitalization 5 042 M 5 042 M -
EV / Sales 2021 1,26x
EV / Sales 2022 1,13x
Nbr of Employees 6 500
Free-Float 85,7%
Duration : Period :
The Chemours Company Technical Analysis Chart | CC | US1638511089 | MarketScreener
Technical analysis trends THE CHEMOURS COMPANY
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 30,53 $
Average target price 40,25 $
Spread / Average Target 31,8%
EPS Revisions
Managers and Directors
Mark E. Newman President, CEO, COO, Director & Senior VP
Sameer Ralhan Chief Financial Officer & Senior Vice President
Mark P. Vergnano Chairman
Randal King VP-Technology & Advanced Performance Materials
Curtis V. Anastasio Independent Director
Sector and Competitors